Private Equity

Elevest Capital acquires a 240-unit complex, signaling a strategic push to modernize older assets amid Charlotte's record construction and shifting rents.

IBP is refinancing debt with a new $500M offering, a move that extends maturity, secures a credit upgrade, and signals strong investor confidence.

Capitol Meridian and Stellex acquire survival gear maker Beaufort, positioning it for major growth and innovation with new investment and veteran leadership.

Two powerhouses are teaming up, using advanced AI to bet big on the booming build-to-rent housing market in the heart of Texas's energy sector.

In a strategic move to become a one-stop shop for medical implants, Resonetics acquires pulse generator tech, targeting the booming neuromodulation and BCI markets.

A Northwest Ohio jail hires Armor Health, promising AI-driven care. But the company's history of hundreds of lawsuits raises serious questions.

Mackenzie Investments' 2026 forecast warns of fewer Fed cuts than expected, highlighting opportunities in AI-driven equities and strategic commodities.

MSC Income Fund nets a massive return on a logistics firm, then reinvests in a merger creating a direct mail powerhouse. Here’s what it means for investors.

Main Street Capital realizes a massive gain from its Mystic Logistics exit and reinvests to merge it with UBM, creating a powerhouse in marketing mail.

A new signature ice cream at the 'Greenest Show on Grass' does more than cool you down—it funds major sustainability projects across Arizona.

The fresh food packaging market is set to soar, but can it balance consumer demands for sustainability, safety, and convenience with the high costs of innovation?

Cosmos Health's subsidiary will manufacture the advanced generic pain reliever PathMuscle, securing a major contract and enhancing its European footprint.

Limbach Holdings appoints M&A and operations expert Terry Dugan to its board, a strategic move aimed at accelerating growth in mission-critical markets.

The acclaimed '1/6' graphic novel series releases its finale, a resistance-driven story that eerily anticipated authoritarian moves in a post-Jan. 6 world.

A new joint venture between Corewell Health and Quest Diagnostics aims to reshape lab services across Michigan with a new high-tech facility and new efficiencies.

As the private equity market rebounds, Evercore hires a seasoned banker to strengthen its financial sponsors group, signaling a major strategic play.

LENZ Therapeutics partners with Lunatus to launch its breakthrough VIZZ™ presbyopia eye drops in the Middle East, targeting a vast, unmet medical need.

AMC Robotics establishes a new manufacturing hub in Ho Chi Minh City, a strategic move to scale its Kyro robot and join the global tech shift to Vietnam.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.